Olgam Life Plasma Donation Center

What Olgam Life Plasma Donation Center does

Olgam Life Plasma Donation Center (legal entity Olgam Life LLC) is a private, FDA-licensed drug manufacturing company that operates a network of walk-in plasma donation centers in the United States. Founded in Brooklyn in 2020 originally to supply convalescent plasma for COVID-19 patients, the company pivoted in 2021 to source plasma collection for pharmaceutical fractionation into immune therapies, clotting factor concentrates, and vaccines. It is one of a small number of independent (non-fractionator-owned) plasma collection operators in the US, differentiating on community-rooted customer service rather than vertical integration.

The core service is automated plasmapheresis, in which blood is drawn, plasma is separated, red blood cells are returned to the donor via sterile saline, and donors are compensated for their time. Centers use a cloud-based donor management system and walk-in access with no appointment required within a 50-mile radius of the donor's address. The product portfolio centers on the donation service itself, supplemented by a VIP donor program for repeat donors, a $50 referral bonus program, and prepaid debit card disbursement through Paysign. Tech integrations are operational rather than novel: Paysign for payments, Mapbox/Google Maps for location, and a third-party SMS reminder system.

The business model collects source plasma from individual donors and sells it wholesale to biopharmaceutical fractionators, while donors receive payment per session (typically $50-60 in NY and $50-140 in FL, with monthly caps of $500-650). Pricing varies by state, first-time vs. repeat donations, and tiered bonuses. Distribution is entirely physical retail: 10 centers across New York City boroughs (Brooklyn, Queens, Bronx, plus upcoming East Harlem and Fordham) and one site in Fort Pierce, Florida. Marketing is community-based, leveraging TikTok, Facebook, LinkedIn, blog content, and SMS. The customer base is segmented horizontally around individual adult donors (ages 18-64, minimum 110 lbs) seeking supplemental income, with claimed reach of 100,000+ people helped. The company has no disclosed funding rounds, no parent company, no subsidiaries, and no listed patents or awards.

Name

Olgam Life Plasma Donation Center

Legal name

Olgam Life LLC

Website

https://olgam.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

51–100 employees

Short description

Olgam Life is an FDA-licensed, private US plasma collection operator running ten walk-in plasma donation centers across NYC and Florida, paying individual donors for source plasma that is sold to biopharmaceutical fractionators.

Ownership category

akta.pro rank

Product category

Plasma Donation Services

NAICS

Blood and Organ Banks (621991)

akta.pro primary industry

Plasma Collection & Donor Services (Plasmapheresis Centers) (HLAIAHAH)

akta.pro secondary industries

Plasma-Derived Therapeutics (immunoglobulins, albumin, clotting factors) (HLAAAAAI), Plasma-Derived & Blood Products Distributors (HLAIAJAJ)

Keywords

• Plasma donation services
• Source plasma collection
• Plasmapheresis services
• FDA-licensed plasma center
• Biologics manufacturing

Headquarters

HQ city

Brooklyn

HQ country

United States

HQ region

North America

Offices11 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

1. Plasma Donation Compensation: Donors receive payment for their time donating plasma. Payments are loaded onto prepaid debit cards immediately after donation. The company collects source plasma for fractionation and manufacturing into biopharmaceutical products including immune therapies, clotting factor concentrates, and vaccines.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Olgam Life operates a network of walk-in plasma donation centers across New York City and Florida where eligible donors give source plasma through an automated plasmapheresis process and are compensated for their time. The collected source plasma is supplied to biopharmaceutical manufacturers for fractionation into therapies such as immune globulins, clotting factor concentrates, and vaccines. The company runs the centers as FDA-licensed drug-manufacturing facilities compliant with federal biologics regulations.

Product overview

Olgam Life Plasma Donation Center operates a network of plasma donation centers across New York and Florida. The core offering is plasma donation services using plasmapheresis, where donors give plasma and receive compensation via a prepaid debit card system. The portfolio includes the core plasma donation service, a VIP Donor Program for returning donors, a Referral Program for income supplements, and Paysign-powered prepaid debit cards for payment disbursement. The company was founded in 2020 and has grown to 10 locations across New York City and Florida.

Differentiator

Problem solved

Functional benefit

Products and services

• Plasma Donation Services Core walk-in plasma donation service using automated plasmapheresis for eligible adult donors aged 18-64 weighing at least 110 lbs; donors are screened, plasma is separated and collected, red blood cells are returned to the donor, and compensation is loaded onto a prepaid debit card. Source plasma is supplied for manufacturing therapies for immune deficiencies, bleeding disorders, and trauma.

Quantifiable outcome

• Donors can earn up to $500/month in NY and $650/month in FL
• +2 more outcomes

Named customers3 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature1 record

Scale indicators5 records

Recent moves7 records

Expansion highlights4 records

Broad incumbents

• CSL Plasma: CSL Plasma is the world's largest plasma collection network and a subsidiary of CSL Behring, a top-5 global biotech. Directly comparable to Olgam as a paid source plasma collector, but vastly larger, vertically integrated into fractionation, and serving as the dominant direct peer in the US market.
• BioLife Plasma Services: BioLife is a subsidiary of Takeda Pharmaceutical and operates a large network of paid plasma donation centers across the US. It is a direct competitor in source plasma collection with similar donor compensation structures and FDA-licensed operations, but benefits from Takeda's fractionation scale.
• Grifols Plasma: Grifols operates one of the largest plasma collection networks globally, integrated with its own fractionation and immunoglobulin manufacturing operations. Directly comparable business model to Olgam at the collection stage, but materially larger scale and vertically integrated.

Direct peers

• Octapharma Plasma: Octapharma Plasma operates a network of paid source plasma donation centers across the US, integrated with its parent Octapharma AG's fractionation business. Closely comparable to Olgam in operating model, donor compensation structure, and FDA-licensed facility approach.
• Kedrion (KedPlasma US): Kedrion operates source plasma collection centers in the US as part of its integrated plasma products business, directly competing for donors with Olgam. Similar scale and geographic footprint characteristics, with the key difference being Kedrion's integrated fractionation capabilities.
• ImmunoTek Bio Centers: ImmunoTek is an independent plasma collection company operating FDA-licensed centers across the US. Closest comparable peer to Olgam as a non-biotech-owned, mid-sized independent plasma center operator focused on community-based donor acquisition.
• BPL Plasma: BPL Plasma operates source plasma donation centers in the US as part of Bio Products Laboratory, with integrated fractionation. Comparable business model to Olgam in donor operations and compensation, serving the same fractionation supply chain.

Emerging players

• GCAM Plasma: GCAM operates a smaller network of plasma collection centers focused on select US regions. Comparable mid-size independent competitor with similar FDA-licensed operations and donor compensation models, but smaller footprint than Olgam.
• ADMA Biologics (ADMA BioCenters): ADMA BioCenters operates FDA-licensed plasma collection centers that supply raw material for ADMA Biologics' specialty immunoglobulin products. Direct comparable in plasma collection operations with the differentiating factor of vertical integration into specialty fractionation.

Regional players

• Interstate Blood Bank: Interstate Blood Bank operates plasma collection and blood banking services across select US regions. Comparable in core FDA-regulated donor operations but with a heavier emphasis on blood banking rather than source plasma fractionation supply.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/profile.php?id=100083374357655
• LinkedInlinkedin.com/company/olgam-life
• TikToktiktok.com/@olgam_lifeplasmadonation

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Olgam Life Plasma Donation Center